Abstract

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria

Borrmann S, Peto T, Snow RW, Gutteridge W, White NJ
PLoS Med. 2008;5

Permenent descriptor
https://doi.org/10.1371/journal.pmed.0050227


No abstract available

Publication metrics
Dimensions Badge

Altmetric

Key Terms
Animals | Antimalarials/ therapeutic use | Clinical Trials, Phase III as Topic | Drug Therapy, Combination | Humans | Malaria, Falciparum/ drug therapy/mortality/parasitology/prevention & control | Plasmodium falciparum/drug effects | Recurrence/prevention & control | Survival Analysis | Treatment Outcome (Source: Medline)
Funded by
Wellcome Trust [079080] Funding Source: Medline
External Sources
Abstract at pubmed
Full text at publishers website
Full text at PMC